Effects of intragastric tryptophan on acute changes in the plasma tryptophan/large neutral amino acids ratio and relationship with subsequent energy intake in lean and obese men. 2020

Maryam Hajishafiee, and Sina S Ullrich, and Robert E Steinert, and Sally D Poppitt, and Natalie D Luscombe-Marsh, and Michael Horowitz, and Christine Feinle-Bisset
Adelaide Medical School and Centre of Research Excellence in Translating Nutritional Science to Good Health, University of Adelaide, Adelaide, Australia. christine.feinle@adelaide.edu.au.

Circulating tryptophan/large neutral amino acids (tryptophan/LNAA) ratio, an indicator of brain serotonin levels, may be important in appetite regulation, together with gastrointestinal (gastric emptying, plasma cholecystokinin) mechanisms. We have compared effects of intragastric tryptophan ('Trp') on the plasma tryptophan/LNAA ratio in lean and obese men, and the associations of the tryptophan/LNAA ratio, gastric emptying and CCK concentrations with energy intake. Lean and obese male participants (n = 16 each) received 3 g Trp or volume-matched control intragastrically, 15 min before a mixed-nutrient drink (300 mL, 400 kcal) (t = 0 min) in randomised, double-blind fashion. Plasma amino acid (for calculation of the plasma tryptophan/LNAA ratio) and CCK concentrations were measured from t = -20-60 min. Gastric emptying was assessed from t = 0-60 min, and ad-libitum energy intake from a standardised buffet-style meal from t = 60-90 min. The increase in the plasma tryptophan/LNAA ratio was less in obese, than lean, participants (P < 0.05), and greater in lean participants who reduced their energy intake (by >0 kcal) after Trp compared with those who did not (by ≤0 kcal) (P < 0.05). Moreover, in participants who reduced their energy intake, the ratio was lower in obese, than in lean (P < 0.05). There was a trend for an inverse correlation between energy intake with the plasma tryptophan/LNAA ratio in lean (r = -0.4, P = 0.08), but not in obese, participants. There was no significant difference in gastric emptying or CCK between participants who reduced their energy intake and those who did not. In conclusion, the plasma tryptophan/LNAA ratio appears to be a determinant of the suppression of energy intake in response to tryptophan in normal-weight people, but not in those with obesity. The role of the plasma tryptophan/LNAA ratio to regulate energy intake, and potential changes in obesity, warrant evaluation in prospective studies.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D002149 Energy Intake Total number of calories taken in daily whether ingested or by parenteral routes. Caloric Intake,Calorie Intake,Intake, Calorie,Intake, Energy
D002766 Cholecystokinin A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety. Pancreozymin,CCK-33,Cholecystokinin 33,Uropancreozymin
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005746 Gastric Emptying The evacuation of food from the stomach into the duodenum. Emptying, Gastric,Emptyings, Gastric,Gastric Emptyings
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino

Related Publications

Maryam Hajishafiee, and Sina S Ullrich, and Robert E Steinert, and Sally D Poppitt, and Natalie D Luscombe-Marsh, and Michael Horowitz, and Christine Feinle-Bisset
March 1994, Biological psychiatry,
Maryam Hajishafiee, and Sina S Ullrich, and Robert E Steinert, and Sally D Poppitt, and Natalie D Luscombe-Marsh, and Michael Horowitz, and Christine Feinle-Bisset
April 2018, Nutrients,
Maryam Hajishafiee, and Sina S Ullrich, and Robert E Steinert, and Sally D Poppitt, and Natalie D Luscombe-Marsh, and Michael Horowitz, and Christine Feinle-Bisset
January 2001, Nutritional neuroscience,
Maryam Hajishafiee, and Sina S Ullrich, and Robert E Steinert, and Sally D Poppitt, and Natalie D Luscombe-Marsh, and Michael Horowitz, and Christine Feinle-Bisset
November 1983, Experimental and clinical endocrinology,
Maryam Hajishafiee, and Sina S Ullrich, and Robert E Steinert, and Sally D Poppitt, and Natalie D Luscombe-Marsh, and Michael Horowitz, and Christine Feinle-Bisset
February 2011, Psychiatry research,
Maryam Hajishafiee, and Sina S Ullrich, and Robert E Steinert, and Sally D Poppitt, and Natalie D Luscombe-Marsh, and Michael Horowitz, and Christine Feinle-Bisset
March 1995, Life sciences,
Maryam Hajishafiee, and Sina S Ullrich, and Robert E Steinert, and Sally D Poppitt, and Natalie D Luscombe-Marsh, and Michael Horowitz, and Christine Feinle-Bisset
January 1985, Journal of neural transmission,
Maryam Hajishafiee, and Sina S Ullrich, and Robert E Steinert, and Sally D Poppitt, and Natalie D Luscombe-Marsh, and Michael Horowitz, and Christine Feinle-Bisset
January 1996, Journal of affective disorders,
Maryam Hajishafiee, and Sina S Ullrich, and Robert E Steinert, and Sally D Poppitt, and Natalie D Luscombe-Marsh, and Michael Horowitz, and Christine Feinle-Bisset
January 1996, Advances in experimental medicine and biology,
Maryam Hajishafiee, and Sina S Ullrich, and Robert E Steinert, and Sally D Poppitt, and Natalie D Luscombe-Marsh, and Michael Horowitz, and Christine Feinle-Bisset
January 1994, Neuropsychobiology,
Copied contents to your clipboard!